Introduction: As the world grapples with an unprecedented dengue outbreak, AVITHRAPID project - participated by Chelonia Applied Science - is poised at the forefront of developing a new pipeline of therapeutic solutions. This initiative aims to address not only dengue but also other infectious diseases like Zika, highlighting the commitment to combating global health threats.
Global Surge in Dengue Cases: Since 2021, the frequency and severity of dengue outbreaks have dramatically increased. The World Health Organization (WHO) reported more than 12.7 million cases and 8,791 deaths between January and September 2024 alone, nearly doubling the figures from the previous year. This alarming trend is particularly pronounced in the Americas but is now expanding into the Eastern Mediterranean and European regions, signaling a growing global challenge.
Contributing Factors. The rapid spread of dengue is fueled by several factors:
Climate Change: Increasing temperatures and changing precipitation patterns have expanded the habitats of Aedes mosquitoes, the primary vectors of the virus.
Urbanization and Mobility: Unplanned urban growth and frequent international travel have facilitated the spread of dengue to new areas.
Economic and Health Implications: The economic impact of dengue fever is staggering, with potential losses due to climate change-related health issues predicted to reach $12.5 trillion by 2050. This includes over $1.1 trillion in additional healthcare costs, underscoring the need for effective prevention and treatment strategies.
AVITHRAPID's Role: AVITHRAPID project is developing a pipeline of preclinical and clinical candidates aimed at providing effective treatment options for diseases like dengue and Zika. By leveraging cutting-edge research and development, AVITHRAPID seeks to introduce novel therapeutic solutions that can be rapidly deployed to mitigate the impacts of these diseases on global health.
Global Strategic Response: In response to the escalating dengue crisis, the WHO has initiated a comprehensive strategic plan that calls for international cooperation and substantial investment in disease management. The plan emphasizes:
Emergency Coordination: Streamlining global and regional responses.
Surveillance and Community Engagement: Enhancing detection and prevention through community-based efforts.
Innovative Treatment Solutions: Developing and deploying new treatments and vaccines.
Conclusion: The ongoing dengue epidemic serves as a stark reminder of our interconnected vulnerabilities in the face of climate change and globalization. With projects like AVITHRAPID, Chelonia is dedicated to pioneering advancements that not only address immediate health challenges but also prepare us for future threats. Join us in this vital effort to enhance global health security and resilience.
Useful links: